This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1977 Nov 24;55(1):43-8.

doi: 10.1007/BF00432815.

On the interaction of drugs with the cholinergic nervous system. VI. Tolerance to physostigmine in mice

S Maayani, Y Egozi, I Pinchasi, M Sokolovsky

PMID: 414260
DOI: 10.1007/BF00432815

On the interaction of drugs with the cholinergic nervous system. VI. Tolerance to physostigmine in mice

S Maayani et al. Psychopharmacology (Berl). 1977.

. 1977 Nov 24;55(1):43-8.

doi: 10.1007/BF00432815.

Authors

S Maayani, Y Egozi, I Pinchasi, M Sokolovsky

PMID: 414260
DOI: 10.1007/BF00432815

No abstract available

PubMed Disclaimer

Similar articles

On the interaction of drugs with the cholinergic nervous system--V. Characterization of some effects induced by physostigmine in mice: in vivo and in vitro studies.
Maayani S, Egozi Y, Pinchasi I, Sokolovsky M. Maayani S, et al. Biochem Pharmacol. 1978 Jan 15;27(2):203-11. doi: 10.1016/0006-2952(78)90302-7. Biochem Pharmacol. 1978. PMID: 623676 No abstract available.
Scopolamine reversal of tremor produced by low doses of physostigmine in rats: evidence for a cholinergic mechanism.
Stanford JA, Fowler SC. Stanford JA, et al. Neurosci Lett. 1997 Apr 11;225(3):157-60. doi: 10.1016/s0304-3940(97)00207-3. Neurosci Lett. 1997. PMID: 9147394
Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Mishkin M. Aigner TG, et al. Psychopharmacology (Berl). 1987;92(3):292-300. doi: 10.1007/BF00210833. Psychopharmacology (Berl). 1987. PMID: 3114781
[Central anticholinergic syndrome during postoperative period].
Rupreht J, Dworacek B. Rupreht J, et al. Ann Fr Anesth Reanim. 1990;9(3):295-304. doi: 10.1016/s0750-7658(05)80190-x. Ann Fr Anesth Reanim. 1990. PMID: 2196841 Review. French.
Update on cholinergic enhancement therapy for Alzheimer disease.
Read SL. Read SL. Bull Clin Neurosci. 1987;52:34-7. Bull Clin Neurosci. 1987. PMID: 3334548 Review.

See all similar articles

Cited by

On the interaction of drugs with the cholinergic nervous system. II. Cross-tolerance between phencyclidine derivatives and cholinergic drugs.
Pinchasi I, Maayani S, Egozi Y, Sokolovsky M. Pinchasi I, et al. Psychopharmacology (Berl). 1978 Jan 31;56(1):37-40. doi: 10.1007/BF00571405. Psychopharmacology (Berl). 1978. PMID: 415324
Altered pilocarpine- or chlorpromazine-induced catalepsy after long-term treatment with cholinergic drugs.
Gianutsos G. Gianutsos G. Psychopharmacology (Berl). 1979 Nov;66(2):121-5. doi: 10.1007/BF00427618. Psychopharmacology (Berl). 1979. PMID: 119254
Environmental influences on the development of tolerance to the effects of physostigmine on schedule-controlled behavior.
Genovese RF, Elsmore TF, Witkin JM. Genovese RF, et al. Psychopharmacology (Berl). 1988;96(4):462-7. doi: 10.1007/BF02180025. Psychopharmacology (Berl). 1988. PMID: 3149767

References

1. J Pharmacol Exp Ther. 1967 Apr;156(1):85-91 - PubMed
1. J Pharmacol Exp Ther. 1953 Dec;109(4):413-6 - PubMed
1. Arch Gen Psychiatry. 1973 Apr;28(4):542-7 - PubMed
1. Br J Pharmacol. 1973 Jan;47(1):138-40 - PubMed
1. Psychopharmacologia. 1974 Feb 6;34(4):317-24 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer